Production (Stage)
CG Oncology, Inc.
CGON
$25.46
-$0.40-1.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 688.43M | 742.00M | 540.71M | 552.88M | 566.51M |
| Total Receivables | 345.00K | 781.00K | 137.00K | 182.00K | 153.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.41M | 11.43M | 11.23M | 10.80M | 11.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 701.19M | 754.21M | 552.08M | 563.86M | 578.61M |
|
|
|||||
| Total Current Assets | 701.19M | 754.21M | 552.08M | 563.86M | 578.61M |
| Net Property, Plant & Equipment | 1.30M | 493.00K | 338.00K | 413.00K | 445.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.69M | 94.00K | 53.00K | 53.00K | 53.00K |
| Total Assets | 728.18M | 754.80M | 552.47M | 564.33M | 579.11M |
|
|
|||||
| Total Accounts Payable | 6.73M | 6.52M | 4.08M | 4.49M | 4.66M |
| Total Accrued Expenses | 15.18M | 14.23M | 11.11M | 6.99M | 4.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 255.00K | 186.00K | 225.00K | 237.00K | 220.00K |
| Total Finance Division Other Current Liabilities | 481.00K | 436.00K | 221.00K | 131.00K | 282.00K |
| Total Other Current Liabilities | 481.00K | 436.00K | 221.00K | 131.00K | 282.00K |
| Total Current Liabilities | 22.64M | 21.37M | 15.63M | 11.85M | 9.98M |
|
|
|||||
| Total Current Liabilities | 22.64M | 21.37M | 15.63M | 11.85M | 9.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 781.00K | 52.00K | 71.00K | 118.00K | 184.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.42M | 21.42M | 15.70M | 11.97M | 10.17M |
|
|
|||||
| Common Stock & APIC | 957.19M | 951.36M | 722.95M | 718.14M | 715.81M |
| Retained Earnings | -252.43M | -217.98M | -186.18M | -165.78M | -146.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M |
|
|
|||||